Tag: directional DBS
FDA grants Aleva Neurotherapeutics approval for IDE study with directSTIM system
Aleva Neurotherapeutics has received a letter of approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) study assessing...
Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...
Directional deep brain stimulation (DBS) has demonstrated benefits over omnidirectional DBS for the treatment of Parkinson’s disease in the largest prospective study in this...
New study reports directional DBS provides superior results to omnidirectional DBS...
Results from a multi-centre, prospective, blinded, crossover study, presented at the North American Neuromodulation Society (NANS) virtual meeting (15–16 January) by Jan Vesper (Heinrich-Heine...
